3PGF image
Deposition Date 2010-11-01
Release Date 2011-03-09
Last Version Date 2024-11-06
Entry Detail
PDB ID:
3PGF
Title:
Crystal structure of maltose bound MBP with a conformationally specific synthetic antigen binder (sAB)
Biological Source:
Source Organism:
Escherichia coli (Taxon ID: 83333)
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.10 Å
R-Value Free:
0.22
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
C 2 2 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Maltose-binding periplasmic protein
Gene (Uniprot):malE
Mutagens:r367n delta (368-370)
Chain IDs:A
Chain Length:398
Number of Molecules:1
Biological Source:Escherichia coli
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:SAB Heavy Chain
Chain IDs:B (auth: H)
Chain Length:231
Number of Molecules:1
Biological Source:Homo sapiens
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:SAB Light Chain
Chain IDs:C (auth: L)
Chain Length:215
Number of Molecules:1
Biological Source:Homo sapiens
Peptide-like Molecules
PRD_900001
Primary Citation
Allosteric control of ligand-binding affinity using engineered conformation-specific effector proteins.
Nat.Struct.Mol.Biol. 18 437 442 (2011)
PMID: 21378967 DOI: 10.1038/nsmb.2002

Abstact

We describe a phage display methodology for engineering synthetic antigen binders (sABs) that recognize either the apo or the ligand-bound conformation of maltose-binding protein (MBP). sABs that preferentially recognize the maltose-bound form of MBP act as positive allosteric effectors by substantially increasing the affinity for maltose. A crystal structure of a sAB bound to the closed form of MBP reveals the basis for this allosteric effect. We show that sABs that recognize the bound form of MBP can rescue the function of a binding-deficient mutant by restoring its natural affinity for maltose. Furthermore, the sABs can enhance maltose binding in vivo, as they provide a growth advantage to bacteria under low-maltose conditions. The results demonstrate that structure-specific sABs can be engineered to dynamically control ligand-binding affinities by modulating the transition between different conformations.

Legend

Protein

Chemical

Disease

Primary Citation of related structures